TREATMENT OF OPHTHALMOLOGIC DISEASES
The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
13.05.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The current invention relates to the use of antibodies which bind to VEGF and ANG2 for the treatment of ophthalmologic diseases. |
---|---|
Bibliography: | Application Number: US202016985477 |